An interventional study of Enhanced Usual Care Group in Hypertension, sponsored by Tufts University. Enrolling by invitation at 2 sites in Ghana. Open to participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-18.
Sponsored by Tufts University · Not applicable, Interventional, and Other
A single-arm study to assess the ability of the AHOMKA platform for hypertension management to affect blood pressure change among urban and rural patients in Ghana.
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's planned enrollment of 160 is above the median of 100 across 4,575 interventional studies indexed under Hypertension.
Browse Hypertension studies →Tufts University is the lead sponsor of 228 studies on the registry; 23 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 8 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with uncontrolled hypertension and the owner of a cell phone are selected. Participants will receive usual care as determined by their provider.
Behavioral: Enhanced Usual Care Group
A culturally-adapted mobile health platform will be used in the intervention to enable participants to record blood pressure and heart rate readings at home and store data in the mobile platform. Providers will have access to the store data using a provider-facing app.
Change in Blood Pressure levels from Baseline
Changes in blood pressure levels, measured in mmHg, will be assessed at the baseline and 6-month endline visit.
Time frame: Baseline, 6 months
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.